Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 2/20 | 0.36 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.35 |
| ▸ | CHRNG | P07510 | 1/20 | 0.35 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | CHRND | Q07001 | 1/20 | 0.35 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10074530 | 0.87 | HCAR3 (0.37) | CHRNA1CHRNGCHRNB1CHRNB2SLC6A2 | |
| SCHEMBL10074528 | 0.85 | HCAR3 (0.36) | CHRNA1CHRNGCHRNB1CHRNB2SLC6A2 | |
| SCHEMBL8237967 | 0.84 | PKM (0.34) | PKM | |
| SCHEMBL4115606 | 0.73 | CNR1 (0.51) | BACE1CNR1 | |
| SCHEMBL20291002 | 0.73 | CNR1 (0.51) | BACE1CNR1 | |
| SCHEMBL10074529 | 0.72 | HCAR3 (0.40) | BACE1CHRNA1CHRNGCHRNB1CHRNB2 | |
| SCHEMBL4232269 | 0.71 | CNR1 (0.44) | BACE1CHRNA1CHRNGCHRNB1CHRNB2 | |
| SCHEMBL4511881 | 0.70 | CNR1 (0.43) | BACE1CHRNA1CHRNGCHRNB1CHRNB2 | |
| SCHEMBL4510496 | 0.69 | CNR1 (0.48) | BACE1CNR1 | |
| SCHEMBL7558158 | 0.69 | KMT2A (0.37) | BACE1CHRNA1CHRNGCHRNB1CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110682-B2 | Preparation and use of compounds as aspartyl protease inhibitors | SCHERING CORPORATION (US) | 2012-02-07 | — | — | US | disclosed |
| US-8110682-B2 | Preparation and use of compounds as aspartyl protease inhibitors | SCHERING CORPORATION (US) | 2012-02-07 | — | — | US | disclosed |
| US-20070010667-A1 | Preparation and use of compounds as aspartyl protease inhibitors | SCHERING CORPORATION | 2007-01-11 | — | — | US | disclosed |
| US-20070010667-A1 | Preparation and use of compounds as aspartyl protease inhibitors | SCHERING CORPORATION | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010667-A1 | Preparation and use of compounds as aspartyl protease inhibitors | PRSS1, CTSS, CTSL | BACE1 11/4885CHRNA1 469/4885CHRNG 253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.